{
 "name": "訊聯",
 "slug": "tw-1784",
 "aliases": [
  "訊聯生物科技股份有限公司",
  "BIONET CORP.",
  "1784"
 ],
 "ticker": "1784",
 "industry": "生技醫療業",
 "website": "http://www.BionetCorp.com",
 "summary": "訊聯（1784）是上櫃的生技醫療類股公司，2000 年成立，2007 年上櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "訊聯生物科技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "英文簡稱",
   "value": "BIONET CORP.",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心上櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "上櫃日期",
   "value": "2007-07-26",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "成立日期",
   "value": "2000-08-17",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "董事長",
   "value": "蔡政憲",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "總經理",
   "value": "康清原",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "實收資本額",
   "value": 531211910,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "公司網址",
   "value": "http://www.BionetCorp.com",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 97039,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源與混入說明之網址不符本次白名單；已回查官方115年09月營收申報，出表日期1151017，原claim/value/unit/as_of一致，僅修正source並補本註記。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": 7.4,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源與混入說明之網址不符本次白名單；已回查官方115年09月營收申報，出表日期1151017，原claim/value/unit/as_of一致，僅修正source並補本註記。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": 9.74,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源與混入說明之網址不符本次白名單；已回查官方115年09月營收申報，出表日期1151017，原claim/value/unit/as_of一致，僅修正source並補本註記。"
  },
  {
   "claim": "管線：BU-01（異體臍帶間質幹細胞；肺纖維化）",
   "value": "肺纖維化｜臨床第二期｜地區未逐項披露",
   "unit": "",
   "as_of": "2025-12-19",
   "source": "https://www.bionetcorp.com/uploads/download/1141219%20%20%28%E8%A8%8A%E8%81%AF%E7%94%9F%E6%8A%80%29%E6%B3%95%E8%AA%AA%E7%B0%A1%E5%A0%B1-%E4%B8%8A%E5%82%B3%E7%89%88_1219181358.pdf",
   "note": "PDF第12、47頁；1784法說明確列為「訊聯集團」管線，研發主體為集團訊聯細胞智藥（7808），非1784母公司直接取得上市藥證。臨床前與CDE輔導均不等於IND核准或上市核准；未配到NCT號。"
  },
  {
   "claim": "管線：BU-01（異體臍帶間質幹細胞；ARDS）",
   "value": "急性呼吸窘迫症候群｜臨床第二期｜地區未逐項披露",
   "unit": "",
   "as_of": "2025-12-19",
   "source": "https://www.bionetcorp.com/uploads/download/1141219%20%20%28%E8%A8%8A%E8%81%AF%E7%94%9F%E6%8A%80%29%E6%B3%95%E8%AA%AA%E7%B0%A1%E5%A0%B1-%E4%B8%8A%E5%82%B3%E7%89%88_1219181358.pdf",
   "note": "PDF第12、47頁；1784法說明確列為「訊聯集團」管線，研發主體為集團訊聯細胞智藥（7808），非1784母公司直接取得上市藥證。臨床前與CDE輔導均不等於IND核准或上市核准；未配到NCT號。"
  },
  {
   "claim": "管線：BU-01（異體臍帶間質幹細胞；CKD）",
   "value": "慢性腎衰竭｜臨床前｜地區未逐項披露",
   "unit": "",
   "as_of": "2025-12-19",
   "source": "https://www.bionetcorp.com/uploads/download/1141219%20%20%28%E8%A8%8A%E8%81%AF%E7%94%9F%E6%8A%80%29%E6%B3%95%E8%AA%AA%E7%B0%A1%E5%A0%B1-%E4%B8%8A%E5%82%B3%E7%89%88_1219181358.pdf",
   "note": "PDF第12、47頁；1784法說明確列為「訊聯集團」管線，研發主體為集團訊聯細胞智藥（7808），非1784母公司直接取得上市藥證。臨床前與CDE輔導均不等於IND核准或上市核准；未配到NCT號。"
  },
  {
   "claim": "管線：BU-01（異體臍帶間質幹細胞；慢性傷口）",
   "value": "慢性傷口｜臨床前｜地區未逐項披露",
   "unit": "",
   "as_of": "2025-12-19",
   "source": "https://www.bionetcorp.com/uploads/download/1141219%20%20%28%E8%A8%8A%E8%81%AF%E7%94%9F%E6%8A%80%29%E6%B3%95%E8%AA%AA%E7%B0%A1%E5%A0%B1-%E4%B8%8A%E5%82%B3%E7%89%88_1219181358.pdf",
   "note": "PDF第12、47頁；1784法說明確列為「訊聯集團」管線，研發主體為集團訊聯細胞智藥（7808），非1784母公司直接取得上市藥證。臨床前與CDE輔導均不等於IND核准或上市核准；未配到NCT號。"
  },
  {
   "claim": "管線：ExoTear（外泌體）",
   "value": "乾眼症｜臨床前；CDE指標性案件113IDX03007｜地區未逐項披露",
   "unit": "",
   "as_of": "2025-12-19",
   "source": "https://www.bionetcorp.com/uploads/download/1141219%20%20%28%E8%A8%8A%E8%81%AF%E7%94%9F%E6%8A%80%29%E6%B3%95%E8%AA%AA%E7%B0%A1%E5%A0%B1-%E4%B8%8A%E5%82%B3%E7%89%88_1219181358.pdf",
   "note": "PDF第12、47頁；1784法說明確列為「訊聯集團」管線，研發主體為集團訊聯細胞智藥（7808），非1784母公司直接取得上市藥證。臨床前與CDE輔導均不等於IND核准或上市核准；未配到NCT號。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-23",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-1784.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}